Honz Pharmaceutical Cash Flow Statement

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022
Net Income	-234.03	-216.21	11.53	-187.58	10.99
Depreciation & Amortization	67.84	63.14	77.43	50.25	44.66
Other Amortization	9.64	13.13	12.7	9.52	12.11
Loss (Gain) From Sale of Assets	-0.47	0.23	-0.72	2.8	-0.07
Asset Writedown & Restructuring Costs	84.38	62.63	12.79	34.06	0.42
Loss (Gain) From Sale of Investments	-1.45	-16.69	-	4.79	-46.79
Provision & Write-off of Bad Debts	-	-4	2.48	13	13.52
Other Operating Activities	5.99	32.65	22.53	19.38	24.7
Change in Accounts Receivable	76.19	92.7	2.71	23.02	-49.6
Change in Inventory	28.26	35.58	-67.6	33.72	10.57
Change in Accounts Payable	110.47	15.85	-8.17	54.77	-13.38
Operating Cash Flow	121.24	71.46	70.69	29.32	11.33
Operating Cash Flow Growth	69.66%	1.08%	141.09%	158.82%	-
Capital Expenditures	-92.12	-92.5	-137.56	-58.9	-219.97
Sale of Property, Plant & Equipment	0.08	0.36	5.52	2.74	0.14
Cash Acquisitions	-	-1.25	-1.16	-	-
Divestitures	-	9.48	-	37.74	333.49
Investment in Securities	-	-	-	-	-27
Other Investing Activities	-0.05	-	73.72	31.8	4.26
Investing Cash Flow	-92.09	-83.91	-59.48	13.38	90.92
Long-Term Debt Issued	252.93	170.94	159.55	245.59	380.7
Total Debt Issued	252.93	170.94	159.55	245.59	380.7
Long-Term Debt Repaid	-314.36	-180.87	-267.3	-255.77	-436.89
Total Debt Repaid	-314.36	-180.87	-267.3	-255.77	-436.89
Net Debt Issued (Repaid)	-61.44	-9.93	-107.74	-10.18	-56.19
Issuance of Common Stock	-	15.94	-	-	13.72
Common Dividends Paid	-16.49	-19.87	-24.34	-26.51	-40.68
Other Financing Activities	-	-0.2	0.3	-	-26.46
Financing Cash Flow	-77.93	-14.06	-131.79	-36.69	-109.61
Foreign Exchange Rate Adjustments	-0.02	0.05	-0	0.13	0.11
Net Cash Flow	-48.79	-26.47	-120.57	6.14	-7.25
Free Cash Flow	29.12	-21.04	-66.87	-29.57	-208.64
Free Cash Flow Margin	6.25%	-4.45%	-9.04%	-5.52%	-24.94%
Free Cash Flow Per Share	0.06	-0.05	-0.15	-0.07	-0.46
Cash Income Tax Paid	40.37	64.58	36.1	29.57	62.33
Levered Free Cash Flow	92.8	13.89	-135.65	-18.76	-236.8
Unlevered Free Cash Flow	92.8	27.06	-119.84	-1.64	-225.09
Change in Working Capital	189.33	136.57	-68.04	83.11	-48.21

Source: S&P Global Market Intelligence. Standard template. Financial Sources.